TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RARE

Ultragenyx

Healthcare · Biotechnology

15.20$ +3.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Ultragenyx (RARE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -466 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RARE
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-5.8 -13 -31 -45 -106 -161 -254 -291 -345 -132 -339 -380 -475 -414 -466
0.0 0.3 0.4 0.7 1.4 3.4 5.8 20 8.5 12 13 18 26 36 35
0.3 0.9 0.7 5.4 25 48 68 80 82 86 105 130 135 158 153
– – – 8.7 31 55 63 -85 83 0.9 0.2 75 – – –
0.5 2.3 -1.5 2.2 7.7 26 -20 -25 -16 105 -63 60 -15 14 -23
0.5 1.1 0.4 2.1 5.0 10 2.8 4.1 25 44 73 146 47 7.5 6.0
-0.9 -1.2 -48 -123 -292 90 56 -33 -13 -179 -195 -292 168 -18 236
– – – 4.3 0.0 0.0 0.0 – – – – – – – –
– – – 189 468 87 141 299 340 525 40 11 – – –
– – – -4.9 -4.9 -4.9 -4.9 – – – – – – – –
17 89 0.2 185 468 139 136 337 679 600 119 501 388 399 478
11 76 -79 17 69 68 -61 12 321 290 -417 -172 82 -35 253
-6.4 -14 -32 -47 -111 -171 -257 -295 -370 -176 -412 -527 -522 -422 -472

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?